Replimune Group, Inc. (REPL)

19.81
0.89 4.30
NASDAQ
Prev Close 20.70
Open 21.08
Day Low/High 19.54 / 21.58
52 Wk Low/High 19.39 / 46.64
Volume 196.74K
Exchange NASDAQ
Shares Outstanding 46.89B
Market Cap 994.14M
P/E Ratio N/A
Div & Yield N.A. (N.A)
Glimmers of Hope in the Biotech Realm as M&A Activity Picks Up

Glimmers of Hope in the Biotech Realm as M&A Activity Picks Up

A recent trio of acquisition deals indicates the doldrums in the sector may be over.

Year-End Good Tidings for 2 Promising Biotechs

Year-End Good Tidings for 2 Promising Biotechs

Omeros Corp. and Eyenovia Inc. were the recipients of positive news this week.

2 Biotech Trades That Illustrate My Investing Strategy

2 Biotech Trades That Illustrate My Investing Strategy

Replimune Group and Akebia Therapeutics provide examples of how to approach stocks in the biotech sector.

2 Small Biotechs to Put on Your 2020 Radar

2 Small Biotechs to Put on Your 2020 Radar

Shares of Replimune Group and Eyenovia have swung up and down in 2019 but should be on the rise next year.

2 Downtrodden Small Biotechs That Are Showing Signs of Life

2 Downtrodden Small Biotechs That Are Showing Signs of Life

T2 Biosystems and Replimune Group have spurted higher in the last couple weeks, with the former doubling in value on encouraging news.